Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dempster

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Lancet. Diabetes & Endocrinology|June 16, 2026
Treatment duration for romosozumabMichael R McClung, David Dempster, Felicia Cosman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2008
Vitamin D economy in blacksFelicia Cosman, Jeri Nieves, David Dempster, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 17, 2019
Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized TrialFelicia Cosman, Donald McMahon, David Dempster, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 21, 2012
Double and quadruple tetracycline labeling of bone: impact of the label itselfRobert Lindsay, Hua Zhou, Felicia Cosman, et al.
Journal of Cellular Biochemistry|August 2, 2007
Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfectaHao Zhang, Stephen B Doty, Christine Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|March 24, 2005
Low bone formation in premenopausal women with idiopathic osteoporosisMarcella A Donovan, David Dempster, Hua Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2015
Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on AlendronateFelicia Cosman, Jeri W Nieves, Marsha Zion, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2021
Bone Marrow Adiposity in Premenopausal Women With Type 2 Diabetes With Observations on Peri-Trabecular AdipocytesVicente F C Andrade, Débora Besen, Domingos C Chula, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 30, 2018
Bone Matrix Mineralization in Patients With Gain-of-Function Calcium-Sensing Receptor Mutations Is Distinctly Different From that in Postsurgical HypoparathyroidismDiana Ovejero, Barbara M Misof, Rachel I Gafni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 5, 2016
Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone-Forming Trabecular SurfacesEleftherios P Paschalis, Sonja Gamsjaeger, David Dempster, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Lancet. Diabetes & Endocrinology|June 16, 2026
Treatment duration for romosozumabMichael R McClung, David Dempster, Felicia Cosman
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2008
Vitamin D economy in blacksFelicia Cosman, Jeri Nieves, David Dempster, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 17, 2019
Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized TrialFelicia Cosman, Donald McMahon, David Dempster, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 21, 2012
Double and quadruple tetracycline labeling of bone: impact of the label itselfRobert Lindsay, Hua Zhou, Felicia Cosman, et al.
Journal of Cellular Biochemistry|August 2, 2007
Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfectaHao Zhang, Stephen B Doty, Christine Hughes, et al.
The Journal of Clinical Endocrinology and Metabolism|March 24, 2005
Low bone formation in premenopausal women with idiopathic osteoporosisMarcella A Donovan, David Dempster, Hua Zhou, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2015
Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on AlendronateFelicia Cosman, Jeri W Nieves, Marsha Zion, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2021
Bone Marrow Adiposity in Premenopausal Women With Type 2 Diabetes With Observations on Peri-Trabecular AdipocytesVicente F C Andrade, Débora Besen, Domingos C Chula, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 30, 2018
Bone Matrix Mineralization in Patients With Gain-of-Function Calcium-Sensing Receptor Mutations Is Distinctly Different From that in Postsurgical HypoparathyroidismDiana Ovejero, Barbara M Misof, Rachel I Gafni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 5, 2016
Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone-Forming Trabecular SurfacesEleftherios P Paschalis, Sonja Gamsjaeger, David Dempster, et al.
Pageof 3